Owkin
Latest round
- Series A
Last raised
- Jun 2020
Total raised
- $61M
Investors
- 10
About Owkin
Owkin, Inc. is a biotechnology firm founded in 2016 in New York, US, specializing in the use of AI for drug development and biomedical research.Owkin specializes in advanced agentic AI platforms designed to facilitate breakthroughs in biomedical research, drug discovery, and diagnostics. The company's core offerings include Owkin K, an agentic AI platform that integrates high-quality multimodal data to generate insights and support decision-making across research teams. Additionally, Owkin has developed OKN4395, a selective triple inhibitor currently in Phase 1 trials, which exemplifies their commitment to leveraging AI throughout the drug development process. Their solutions cater to a diverse clientele, including academic research institutions and pharmaceutical companies, focused on enhancing precision pathology and biomarker discovery.Owkin generates revenue through a combination of partnerships with pharmaceutical companies and academic institutions, providing access to their AI-driven tools and technologies. Their business model includes subscriptions to the Owkin K platform, through which clients can access multimodal data and AI applications for research and clinical development. Additionally, they offer digital pathology solutions that support pathologists in screening biomarkers and predicting patient outcomes, which are essential in clinical trial settings. Revenue from these services may be driven by institutional contracts or licensing agreements that facilitate the integration of Owkin's technologies into existing workflows.In March 2023, Owkin, Inc.00 mn to support its strategy of developing at least 15 AI-based tools aimed at improving cancer diagnosis, discovering new treatment biomarkers, and predicting patient outcomes in hospitals across France. The company plans to expand its AI applications into new markets, particularly focusing on the healthcare landscape in France, driving innovation in cancer care and enhancing diagnostic capabilities.
Who invested in Owkin
10 investors across 5 rounds
See all investors in Owkin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Owkin
Who invested in Owkin?
Owkin has 10 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Owkin raised?
Owkin has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Owkin last raise money?
Owkin's most recent round on record is a Series A, in Jun 2020.
What does Owkin do?
Owkin is a software company.
Where is Owkin headquartered?
Owkin is headquartered in New York, US.
Which VCs invest in companies like Owkin?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Owkin's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like Owkin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.